Media-OutReach Newswire GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae
PM stresses importance of large-scale, symbolic projects by China in Việt Nam in talks with top Chinese leader 1.